Face and head morphogenesis begin early in development, when the brain is beginning to form, and are highly dependent on patterning information provided by emigrant cranial neural crest cells [1] . These cells generate most of the bones and cartilage in the head, and instruct paraxial mesoderm in the formation of appropriate musculature [2] . Molecular cues that differ spatiotemporally along the rostrocaudal axis of the early brain plate affect emerging cranial neural crest cells and predetermine some aspects of their fate, such as whether they generate first or second branchial arch skeletal elements.
Progress in understanding craniofacial development is being greatly facilitated by the recently developed ability to create 'knockout' mice in which a specific gene has been inactivated by homologous recombination. A substantial number of such knockout experiments have identified genes that are essential for craniofacial development. Many of these genes code for DNA-binding transcription factors, and almost all are expressed in specific subregions of cranial neural-crest-derived mesenchyme. Although there is an experimental bias towards knocking-out genes for transcription factors, it is also probably significant that loss of a transcription factor can affect the expression of multiple target genes.
Development of the jaws
Finding that knocking out a particular gene affects craniofacial development has frequently come as a surprise. One good example is provided by knockout mice that lack expression of endothelin-1 (ET-1) [3] , a vasoactive peptide that is expressed in vascular endothelial cells and is thought to be involved in the regulation of blood pressure. Surprisingly, ET-1 -/-mutant mice exhibited no obvious problems in heart or vasculature development, but instead they showed a significant reduction in size of the mandible (lower jaw) and tongue. A retrospective examination of expression patterns in early embryos showed that ET-1 is expressed in oral epithelium in 9.5 day embryos, whereas ET-1 receptors are expressed in nearby osteogenic mesenchyme of the mandibular prominence [4] . Thus, in developing a model for mandibular patterning, it will now be important to include endothelin-1 as an important morphogenetic molecule.
Mandibular development is affected in several other types of knockout mice, including activin receptor type II [5] , goosecoid (gsc) [6, 7] , Hoxa2 [8, 9] , MHox [10] and Msx-1 [11] mutants; the last four genes all encode homeobox domain transcription factors. The mandible has a distinct morphology, with four recognizable processes: the angular, coronoid, condylar and dentoalveolar processes (Fig. 1) . Mutant gsc -/-mice lack the coronoid and angular processes, whereas MHox -/-mice have deficient condylar, angular and coronoid processes. MHox -/-mutants also lack the squamosal bone and the temporo-mandibular joint, which normally forms by the articulation of the condylar process with the squamosal bone. MHox and gsc may [11] . The major craniofacial defect in these mice is a reduction in size of the dentoalveolar process, and missing or delayed development of the teeth. In humans, when teeth are congenitally missing or extracted, the alveolar bone is lost. Thus, the role of Msx-1 in the development or maintenance of the alveolar bone may be secondary to its function in molar development. Msx-1/Msx-2 double mutants exhibit a more severe facial phenotype, and many derivatives of the facial prominences are reduced or absent in such mice (R. Maas, personal communication). Msx family genes appear to be involved in epithelial-mesenchymal interactions during facial and dental development, and their expression may be regulated by BMPs [12] .
The gene Dlx-2, which also encodes a homeodomain protein, is uniformly expressed in the epithelium and neural-crest-specific mesenchyme of the first branchial arch. Surprisingly, inactivation of Dlx-2 affects proximal derivatives of the first arch (including the maxilla), but has no effect on the mandible [13] . There are at least five Dlx family genes in the mouse, and it seems likely that other family members can compensate for loss of Dlx-2 expression in the mandible.
Facial clefting
In order to interpret the phenotype of a strain of knockout mice, it is necessary to identify the particular set of cells that normally express the inactivated gene. Knowledge of where the gene is expressed and the nature of its product can provide strong clues as to whether the effects of the mutation are cell-autonomous or non-cell-autonomousthat is, whether inactivation of the gene affects the developmental fate of the cells where the gene is normally expressed or of other cells that rely in some way on the gene-expressing cells (or both). Such information can also suggest testable models for the morphogenetic process that has been disrupted in the knockout mice. These considerations are well illustrated by the effects of targeted gene inactivation on facial clefting.
Clefts of the secondary palate (the roof of the mouth) are believed to occur when growth of the upper and lower jaws is not coordinated properly (Fig. 2) . For example, the exposure of rat embryos to the teratogen diazo-oxo-norleucine retards mandibular growth so that the tongue remains wedged between the palatal shelves [14] , resulting in a cleft palate. Mice lacking expression of gsc [6, 7] , Msx-1 [11] , Dlx-2 [13] Genes that may directly affect the growth of palatal shelves include Dlx-2 [13] and MHox [10] , and those encoding the transcription factor AP-2 ( [15] and H. Schorle, P. Meier, M. Buchert, R. Jaenisch and P.J.M., unpublished data) and the retinoic acid receptors (RARs) ␣ and ␥ [16] . With the exception of AP-2, mutations of all these genes permit normal elevation of the palatal shelves, but because of their reduced size the medial edges cannot make contact. In AP-2 -/-mutant embryos, head morphogenesis is so severely disrupted that it is difficult to discern the palatal shelves. In wild-type embryos, AP-2 is expressed very early in cranial neural-crest cells and in the crest-derived mesenchyme of the facial prominences, as well as in the ectoderm [15] . The regulation by AP-2 of multiple, critical target genes in these cell types during embryogenesis may account for the severity of the AP-2 mutant phenotype.
In 9 day AP-2 -/-embryos, increased cell death has been observed to occur in proximal mesenchyme of the first branchial arch and in brain plate neuroepithelia, and may reflect cell autonomous and/or non-autonomous roles for AP-2 in survival of these cells. It is tempting to speculate that the neuroepithelial cell death is the direct cause of the subsequent exencephaly -exposure of brain tissues caused by failure of the cranial portion of the neural tube to close -seen in these mice. In any event, changes extrinsic to the neuroepithelial cells -that is, non-autonomous changes -must ultimately underlie their death, as they do not normally express AP-2 at this time [15] .
In mutants lacking TGF-␤3 [17, 18] or activin ␤A/␤B [19] expression, the cleft-palate phenotype is only partially penetrant, and the palatal shelves may be affected only after they have met at the midline. During normal secondary palate development, the medial-edge epithelia of the apposing palatal shelves touch and the mesenchyme invades the seam, ultimately forming a continuous bridge across the roof of the oral cavity. TGF-␤3 is expressed in a highly localized manner in the medial-edge epithelia of the palatal shelves [20] , and in TGF-␤3 mutants the epithelial seam persists in some regions of the palate, preventing complete mesenchymal fusion. Although the palate appears intact on macroscopic inspection, closer examination reveals that the palatine bones do not meet in the midline (termed a submucous cleft). Thus, it appears that TGF-␤3 is critical for fusion of the secondary palate after the shelves have made initial contact.
Clefts involving the primary palate and upper lip are rare (Fig. 3) . Examples of this type of cleft are seen in AP-2 -/-mutants (H. Schorle, P. Meier, M. Buchert, R. Jaenisch and P.J.M., unpublished data), and RAR␣/␥ [16] and Msx-1/Msx-2 double mutants (R. Maas, personal communication). Msx-1/Msx-2 double-mutant mice have exencephaly in combination with bilateral cleft upper lip and cleft secondary palate. These mice may prove to be useful models for human cleft lip and cleft palate disorders. In contrast, the AP-2 and RAR mutants exhibit midline clefts that are not analogous to the more common form of cleft lip seen in humans and certain strains of mice. Midline clefting may be caused by the absence, deficiency or improper growth trajectory of the frontonasal and medial nasal prominences.
AP-2 -/-mutant mice suffer from severe exencephaly (cranioschisis) involving the entire brain (H. Schorle, P. Meier, M. Buchert, R. Jaenisch and P.J.M., unpublished data). In this case, it is possible that midline clefting is a secondary effect of abnormal brain growth, as the frontonasal region is disturbed early in its formation by rostroventral growth of the everted forebrain. The midline cleft lip and other associated frontonasal region defects observed in RAR␣/␥ double mutant mice are suggestive of a deficiency in medial and frontonasal mesenchyme, possibly because of increased cell death in this region [16] . Fusion of the neural folds occurs normally in the forebrain, although about 50 % of the embryos have smaller than normal frontal lobes. There is also a possibility that the abnormal brain growth in RAR␣/␥ double mutant mice is correlated with the midline cleft, as in AP-2 -/-mice. Exencephaly also occurs in mice homozygous for a mutation in twist, which encodes a helix-loop-helix domain transcription factor expressed in cranial neural crest cells and other mesodermal cell types [21] . These mice die at around embryonic day 11.5, apparently of cardiovascular defects. As this stage is sufficiently late for incipient cells of the primary palate to be detected [22] , it should be possible to see whether the open neural tube in twist mutant embryos affects fusion of the facial prominences.
Future prospects
The phenotype of a strain of knockout mice reflects the sum of the functions of the inactivated gene at all stages of development. While the phenotype is sometimes stunning, it is nonetheless of limited use for understanding late functions of genes that are used at multiple times during development, as abnormal early development may mask the gene's later roles. Furthermore, a gene may be expressed in several interacting cell types, so that a particular phenotypic defect could be dependent on deficiencies in any or all of the cell types. On-going and future developments in knockout-mouse technology may help to resolve such complexities
The generation of chimeric mice by injecting mutant embryonic stem cells into wild-type blastocysts may help identify particularly important sites of expression of the inactivated gene (see [21] ) -for example, the presence of mutant cells in a particular tissue may be found to correlate with an aspect of the mutant phenotype. Finally, it is now feasible to try to eliminate a gene product in a spatio-temporally regulated manner during ontogeny, using the Cre-loxP recombination system [23] . This powerful technology will no doubt be applied to the study of craniofacial development in the future, and may provide more information about the roles of various genes in facial morphogenesis.
